Filtros de búsqueda

Lista de obras de Alba A. Brandes

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

artículo científico publicado en 2006

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

artículo científico publicado en 2016

A Randomized Controlled Trial of Tong Len Meditation Practice in Cancer Patients: Evaluation of a Distant Psychological Healing Effect

artículo científico publicado en 2015

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

artículo científico publicado en 2018

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy.

artículo científico publicado en 2014

A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature

artículo científico

A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.

artículo científico publicado en 2005

A multicenter study of the prognosis and treatment of adult brain ependymal tumors.

artículo científico publicado en 2004

A prospective study on glioblastoma in the elderly

artículo científico publicado en 2003

ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

AT-11FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM.

artículo científico publicado en 2014

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM])

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

artículo científico publicado en 2016

Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer.

artículo científico publicado en 2001

Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma.

artículo científico publicado en 2005

Adjuvant chemotherapy in the treatment of high grade gliomas.

artículo científico publicado en 2005

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

artículo científico publicado en 2012

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

artículo científico publicado en 2006

Adjuvant temozolomide: how long and how much?

artículo científico publicado en 2008

Adjuvant therapy in glioblastomas: false steps and real advances.

artículo científico publicado en 2007

Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).

artículo científico publicado en 2009

Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.

artículo científico publicado en 2005

Advances in malignant glioma drug discovery

artículo científico publicado en 2011

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

artículo científico publicado en 2008

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

artículo científico publicado en 2004

Association between response to primary treatments and MGMT status in glioblastoma

artículo científico publicado en 2008

Bevacizumab in brain tumors: ready for primetime?

artículo científico publicado en 2009

Bevacizumab in recurrent glioblastoma: open issues

artículo científico publicado en 2015

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

artículo científico publicado en 2014

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

artículo científico publicado en 2017

Brain metastases from non-small-cell lung cancer: is there room for improvement?

artículo científico publicado en 2012

Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examination

scientific article published on 01 July 2003

Burnout in medical oncology during the COVID-19 pandemic

scientific article published on 23 December 2020

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

artículo científico publicado en 2020

Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

artículo científico publicado en 2014

Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.

artículo científico publicado en 2003

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

artículo científico publicado en 2011

Cardiovascular safety of VEGF-targeting therapies: current evidence and handling strategies

artículo científico publicado en 2010

Challenges and progress in the treatment of adult medulloblastomas.

artículo científico publicado en 2007

Chemotherapy in brain metastases of lung and breast cancer

Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?

artículo científico publicado en 2008

Chemotherapy in patients with recurrent and progressive central neurocytoma

artículo científico publicado en 2000

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

artículo científico publicado en 2014

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

artículo científico publicado en 1990

Clinical end points in recurrent glioblastoma: are antiangiogenic agents friend or foe?

artículo científico publicado en 2011

Contribution of microRNA analysis to characterisation of pancreatic lesions: a review

artículo científico

Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

artículo científico publicado en 2017

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

artículo científico publicado en 2006

Current clinical management of gastrointestinal stromal tumors

artículo científico publicado en 2004

Current management and prognostic factors for adult ependymoma

artículo científico publicado en 2002

Cytologically confirmed splenic metastases in breast cancer

artículo científico publicado en 2012

Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma.

artículo científico publicado en 2002

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

artículo científico publicado en 2008

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

scientific article published on 01 December 2019

EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer

artículo científico publicado en 2012

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

artículo científico publicado en 2012

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

artículo científico publicado en 2009

EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology

ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.

artículo científico publicado en 2014

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

artículo científico publicado en 2017

Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.

artículo científico publicado en 2004

End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era.

artículo científico publicado en 2011

Epidemiology of glial and non-glial brain tumours in Europe

artículo científico publicado en 2012

Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma.

artículo científico publicado en 2017

Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments

artículo científico publicado en 2008

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.

artículo científico publicado en 2003

Fertility preservation in women with CNS tumors

artículo científico publicado en 2017

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy

scientific article published on 21 May 2020

Fine-needle aspiration cytology of adrenal masses in noncancer patients

artículo científico publicado en 2001

First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia

artículo científico publicado en 2004

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2009

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.

artículo científico publicado en 2008

Gangliogliomas: recent advances in classification and treatment

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2007

Glioblastoma in adults

artículo científico publicado en 2008

Glioblastoma in the elderly: current and future trends

artículo científico publicado en 2006

Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial

artículo científico publicado en 2007

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

artículo científico publicado en 2016

High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults.

artículo científico publicado en 2001

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

artículo científico publicado en 2009

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas

scientific article published on 25 July 2020

How to face cancer treatment in the COVID-19 era

scientific article published on 06 May 2020

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2015

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2010

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

scientific article published on 10 May 2019

Immunotherapy in elderly patients: should we stay or should we go?

artículo científico publicado en 2020

Immunotherapy in head and neck cancer: evidence and perspectives

artículo científico publicado en 2017

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

artículo científico publicado en 2015

In Reply

Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study ⬇️

artículo científico publicado el 1 de septiembre de 1997

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

artículo científico publicado en 2016

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

artículo científico publicado en 2017

LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410

artículo científico publicado en 2017

Lomustine and Bevacizumab in Progressive Glioblastoma

artículo científico publicado en 2017

Long-term results of a prospective study on the treatment of medulloblastoma in adults.

artículo científico publicado en 2007

MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years

artículo científico publicado en 2014

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

artículo científico publicado en 2006

MB-52RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) COMMITTEE GUIDELINES FOR RESPONSE ASSESSMENT IN MEDULLOBLASTOMA AND OTHER LEPTOMENINGEAL SEEDING TUMORS.

artículo científico publicado en 2016

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

artículo científico publicado en 2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

artículo científico publicado en 2009

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

artículo científico publicado en 2008

Maintenance therapy in non-small cell lung cancer

artículo científico

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

scientific article published on 07 June 2020

Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?

artículo científico publicado en 2019

Medulloblastoma in adults: clinical characteristics and treatment.

artículo científico publicado en 1999

Medulloblastomas in adults: prognostic factors and lessons from paediatrics

artículo científico publicado en 2011

Metastatic process: the seed and the soil from bench to bedside

artículo científico publicado en 2013

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes ⬇️

artículo científico publicado en 2020

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

artículo científico publicado en 2009

NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION

NI-26COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

artículo científico publicado en 2014

NIMG-51. RADIOLOGIC PHENOTYPES ARE TREATMENT SPECIFIC AND ASSOCIATED WITH SURVIVAL - EXPLORATORY ANALYSIS OF EORTC 26101

artículo científico publicado en 2017

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP.

artículo científico publicado en 2015

NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

Neuro-oncology: Genetic variation in pediatric and adult brain tumors.

artículo científico publicado en 2010

Neuro-oncology: treatment decisions in elderly patients with glioblastoma.

artículo científico publicado en 2012

New Agents and New End Points for Recurrent Gliomas ⬇️

artículo científico publicado el 31 de enero de 2011

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cance

artículo científico publicado en 2013

New drugs in the treatment of elderly patients with metastatic castration-resistance prostate cancer

artículo científico publicado en 2016

New molecular targets and novel anticancer treatments: emerging trends in neuro-oncology.

artículo científico publicado en 2006

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.

artículo científico publicado en 2014

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

artículo científico publicado en 2012

New strategy developments in brain tumor therapy.

artículo científico publicado en 2001

Nitrosoureas in the Management of Malignant Gliomas

artículo científico publicado en 2016

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

artículo científico publicado en 2007

Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria

artículo científico publicado en 2017

Non-cytotoxic therapies for malignant gliomas

artículo científico publicado en 2002

Novel therapeutics in adult malignant brain gliomas

artículo científico publicado en 2005

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

artículo científico publicado en 2010

Optimal management of elderly patients with glioblastoma

artículo científico publicado en 2012

Patient outcomes following second surgery for recurrent glioblastoma

artículo científico publicado en 2016

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

artículo científico publicado en 2014

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

artículo científico publicado en 2015

Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts

artículo científico publicado en 2017

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.

artículo científico publicado en 2017

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).

artículo científico publicado en 2016

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

artículo científico publicado en 2014

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

artículo científico publicado en 2003

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

artículo científico publicado en 2008

Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

artículo científico publicado en 1997

Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis

artículo científico publicado en 2020

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

artículo científico publicado en 2022

Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions

artículo científico publicado en 2002

Post progression survival in glioblastoma: where are we?

artículo científico publicado en 2014

Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

scientific article published on 18 February 2019

Practical management of bevacizumab-related toxicities in glioblastoma

artículo científico publicado en 2015

Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients

artículo científico publicado en 2002

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients.

artículo científico publicado en 2018

Primary brain tumors in the elderly population.

artículo científico publicado en 2011

Prognostic factors for anaplastic astrocytomas

artículo científico publicado en 2006

Prognostic impact of HER-2 Subclonal Amplification in breast cancer

artículo científico publicado en 2017

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

artículo científico publicado en 2012

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

artículo científico publicado en 2007

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

artículo científico publicado en 2011

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

artículo científico publicado en 2010

QLIF-27. THE ADDED VALUE OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AS A PROGNOSTIC INDICATOR OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOMA PATIENTS: A META-ANALYSIS BASED ON INDIVIDUAL PATIENT DATA FROM RANDOMIZED CONTROLLED TRIALS

QOL-07DESCRIPTION OF CLINICAL AND PATIENT REPORTED OUTCOMES ASSESSMENTS FROM A PHASE 3, MULTICENTER, RANDOMIZED TRIAL EVALUATING NIVOLUMAB MONOTHERAPY VERSUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA: CHECKMATE-143.

artículo científico publicado en 2015

QOLP-29. SYMPTOM CLUSTERS IN NEWLY DIAGNOSED GLIOMA PATIENTS: WHICH CLUSTERS ARE ASSOCIATED WITH FUNCTIONING AND GLOBAL HEALTH STATUS?

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

artículo científico publicado en 2006

Radiotherapy of the brain in elderly patients. Contra:.

artículo científico publicado en 2000

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

artículo científico publicado en 2005

Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.

artículo científico publicado en 2006

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

artículo científico publicado en 2009

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA

artículo científico publicado en 2016

Rare Primary Central Nervous System Tumors in Adults: An Overview

artículo científico publicado en 2020

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status

artículo científico publicado en 2009

Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences

artículo científico publicado en 2016

Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer

artículo científico publicado en 2004

Resistance to antiangiogenic therapies

artículo científico publicado en 2014

Response Assessment in Medulloblastoma and Leptomeningeal Seeding Tumors: Recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee

artículo científico publicado en 2017

Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

artículo científico publicado en 2020

Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

artículo científico publicado en 2020

Review of the prognostic factors in medulloblastoma of children and adults.

artículo científico publicado en 2004

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

artículo científico publicado en 2017

Second surgery for recurrent glioblastoma: advantages and pitfalls

artículo científico

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2004

Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study

artículo científico publicado en 2004

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

artículo científico publicado en 2016

Shedding light on adult medulloblastoma: current management and opportunities for advances

artículo científico publicado en 2014

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

artículo científico publicado en 2017

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

artículo científico publicado en 2006

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

artículo científico publicado en 2019

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

artículo científico publicado en 2006

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

artículo científico publicado en 2020

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.

artículo científico publicado en 2001

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

artículo científico publicado en 2016

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

artículo científico publicado en 2009

Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study

artículo científico publicado en 2002

Temozolomide rechallenge in recurrent glioblastoma: when is it useful?

artículo científico publicado en 2018

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

artículo científico publicado en 2008

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.

artículo científico publicado en 2018

The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumors.

artículo científico publicado en 2003

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

artículo científico publicado en 2017

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria

scientific article published on 16 July 2018

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

scientific article published on 13 June 2019

The burden of oncology promises not kept in glioblastoma

The development of platinum compounds and their possible combination

artículo científico publicado en 2006

The effect of re-operation on survival in patients with recurrent glioblastoma

artículo científico publicado en 2015

The metastatic process: a kaleidoscope of concepts

artículo científico publicado en 2014

The pathogenesis and treatment of brain metastases: a comprehensive review.

artículo científico publicado en 2004

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.

artículo científico publicado en 2017

The prognostic role of gender and MGMT methylation status in glioblastoma patients: the female power

artículo científico publicado en 2018

The role of bevacizumab in recurrent glioblastoma: new insights from randomized trials

artículo científico publicado en 2015

The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?

artículo científico publicado en 2018

The role of gender in glioblastoma: does it matter?

The role of systemic and targeted therapies in brain metastases

artículo científico publicado en 2013

The treatment of adults with medulloblastoma: a prospective study

artículo científico publicado en 2003

The treatment of cranial germ cell tumours.

artículo científico publicado en 2000

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview

artículo científico publicado en 2014

Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?

artículo científico publicado en 2018

Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls

artículo científico publicado en 2010

Trastuzumab in CNS progressive metastatic breast cancer.

artículo científico publicado en 2007

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

artículo científico publicado en 2013

Treatment of brain metastases in uncommon tumors.

artículo científico publicado en 2004

Treatment of recurrent glioblastoma: state-of-the-art and future perspectives

artículo científico publicado en 2020

Treatment of recurrent high-grade gliomas

artículo científico publicado en 2009

Treatment options for recurrent glioblastoma: pitfalls and future trends

artículo científico publicado en 2009

Unusual nasal and orbital involvement of glioblastoma multiforme: a case report and review of the literature.

artículo científico publicado en 1998

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda